1 May 2019 - After lengthy negotiations and a court battle, NHS England has reached agreement with three drug companies ...
30 September 2016 - Breakthrough therapy designation granted based on Phase 2 clinical data for genotype 1 patients who failed previous ...
23 September 2016 - A new drug which effectively treats more genotypes of hepatitis C has been recommended for use in ...
9 September 2016 - Another ‘potential curative’ drug for people with chronic hepatitis C will be made available on the NHS. ...
31 August 2016 - The TGA has approved MSD's Zepatier (grazoprevir with elbasvir). ...
5 August 2016 - Sofosbuvir with velpatasvir was originally granted fast track designation by the FDA on 30 September 2013 ...
27 July 2016 - A joint investigation by The BMJ and Cambridge and Bath universities uncovers how NHS England tried to ...
27 July 2016 - Why government must negotiate a better deal for publicly funded research. ...
28 July 2016 - When Gilead Sciences introduced sofosbuvir based antivirals in 2014, the drugs were touted as a breakthrough for ...
27 July 2016 - Victor Roy and Lawrence King argue that the acquisition strategies of drug companies magnify development costs and ...
28 July 2016 - Addaction says NHS England decision to treat just 10,000 people a year with costly drugs is ‘potential ...
28 July 2016 - The EMA has published an EPAR for Merck's Zepatier. ...
28 July 2016 - The EMA has published an EPAR for Gilead's Epclusa. ...
20 July 2016 - CADTH has recommended that asunaprevir (Sunvepra) be reimbursed in Canada. ...
25 July 2016 - New extended-release formulation is the first all-oral, co-formulated treatment containing the three direct-acting antiviral components of Viekira ...